1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI-Enabled Imaging Modalities Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Computed Tomography (CT)
1.2.3 MRI
1.2.4 X-Ray
1.2.5 Ultrasound
1.2.6 Positron Emission Tomography (PET)
1.2.7 Other Modalities
1.3 Market by Application
1.3.1 Global AI-Enabled Imaging Modalities Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cardiology
1.3.3 Oncology
1.3.4 Neurology
1.3.5 Pulmonology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global AI-Enabled Imaging Modalities Market Perspective (2016-2027)
2.2 AI-Enabled Imaging Modalities Growth Trends by Regions
2.2.1 AI-Enabled Imaging Modalities Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 AI-Enabled Imaging Modalities Historic Market Share by Regions (2016-2021)
2.2.3 AI-Enabled Imaging Modalities Forecasted Market Size by Regions (2022-2027)
2.3 AI-Enabled Imaging Modalities Industry Dynamic
2.3.1 AI-Enabled Imaging Modalities Market Trends
2.3.2 AI-Enabled Imaging Modalities Market Drivers
2.3.3 AI-Enabled Imaging Modalities Market Challenges
2.3.4 AI-Enabled Imaging Modalities Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI-Enabled Imaging Modalities Players by Revenue
3.1.1 Global Top AI-Enabled Imaging Modalities Players by Revenue (2016-2021)
3.1.2 Global AI-Enabled Imaging Modalities Revenue Market Share by Players (2016-2021)
3.2 Global AI-Enabled Imaging Modalities Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by AI-Enabled Imaging Modalities Revenue
3.4 Global AI-Enabled Imaging Modalities Market Concentration Ratio
3.4.1 Global AI-Enabled Imaging Modalities Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI-Enabled Imaging Modalities Revenue in 2020
3.5 AI-Enabled Imaging Modalities Key Players Head office and Area Served
3.6 Key Players AI-Enabled Imaging Modalities Product Solution and Service
3.7 Date of Enter into AI-Enabled Imaging Modalities Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI-Enabled Imaging Modalities Breakdown Data by Type
4.1 Global AI-Enabled Imaging Modalities Historic Market Size by Type (2016-2021)
4.2 Global AI-Enabled Imaging Modalities Forecasted Market Size by Type (2022-2027)
5 AI-Enabled Imaging Modalities Breakdown Data by Application
5.1 Global AI-Enabled Imaging Modalities Historic Market Size by Application (2016-2021)
5.2 Global AI-Enabled Imaging Modalities Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America AI-Enabled Imaging Modalities Market Size (2016-2027)
6.2 North America AI-Enabled Imaging Modalities Market Size by Type
6.2.1 North America AI-Enabled Imaging Modalities Market Size by Type (2016-2021)
6.2.2 North America AI-Enabled Imaging Modalities Market Size by Type (2022-2027)
6.2.3 North America AI-Enabled Imaging Modalities Market Size by Type (2016-2027)
6.3 North America AI-Enabled Imaging Modalities Market Size by Application
6.3.1 North America AI-Enabled Imaging Modalities Market Size by Application (2016-2021)
6.3.2 North America AI-Enabled Imaging Modalities Market Size by Application (2022-2027)
6.3.3 North America AI-Enabled Imaging Modalities Market Size by Application (2016-2027)
6.4 North America AI-Enabled Imaging Modalities Market Size by Country
6.4.1 North America AI-Enabled Imaging Modalities Market Size by Country (2016-2021)
6.4.2 North America AI-Enabled Imaging Modalities Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe AI-Enabled Imaging Modalities Market Size (2016-2027)
7.2 Europe AI-Enabled Imaging Modalities Market Size by Type
7.2.1 Europe AI-Enabled Imaging Modalities Market Size by Type (2016-2021)
7.2.2 Europe AI-Enabled Imaging Modalities Market Size by Type (2022-2027)
7.2.3 Europe AI-Enabled Imaging Modalities Market Size by Type (2016-2027)
7.3 Europe AI-Enabled Imaging Modalities Market Size by Application
7.3.1 Europe AI-Enabled Imaging Modalities Market Size by Application (2016-2021)
7.3.2 Europe AI-Enabled Imaging Modalities Market Size by Application (2022-2027)
7.3.3 Europe AI-Enabled Imaging Modalities Market Size by Application (2016-2027)
7.4 Europe AI-Enabled Imaging Modalities Market Size by Country
7.4.1 Europe AI-Enabled Imaging Modalities Market Size by Country (2016-2021)
7.4.2 Europe AI-Enabled Imaging Modalities Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific AI-Enabled Imaging Modalities Market Size (2016-2027)
8.2 Asia-Pacific AI-Enabled Imaging Modalities Market Size by Type
8.2.1 Asia-Pacific AI-Enabled Imaging Modalities Market Size by Type (2016-2021)
8.2.2 Asia-Pacific AI-Enabled Imaging Modalities Market Size by Type (2022-2027)
8.2.3 Asia-Pacific AI-Enabled Imaging Modalities Market Size by Type (2016-2027)
8.3 Asia-Pacific AI-Enabled Imaging Modalities Market Size by Application
8.3.1 Asia-Pacific AI-Enabled Imaging Modalities Market Size by Application (2016-2021)
8.3.2 Asia-Pacific AI-Enabled Imaging Modalities Market Size by Application (2022-2027)
8.3.3 Asia-Pacific AI-Enabled Imaging Modalities Market Size by Application (2016-2027)
8.4 Asia-Pacific AI-Enabled Imaging Modalities Market Size by Region
8.4.1 Asia-Pacific AI-Enabled Imaging Modalities Market Size by Region (2016-2021)
8.4.2 Asia-Pacific AI-Enabled Imaging Modalities Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America AI-Enabled Imaging Modalities Market Size (2016-2027)
9.2 Latin America AI-Enabled Imaging Modalities Market Size by Type
9.2.1 Latin America AI-Enabled Imaging Modalities Market Size by Type (2016-2021)
9.2.2 Latin America AI-Enabled Imaging Modalities Market Size by Type (2022-2027)
9.2.3 Latin America AI-Enabled Imaging Modalities Market Size by Type (2016-2027)
9.3 Latin America AI-Enabled Imaging Modalities Market Size by Application
9.3.1 Latin America AI-Enabled Imaging Modalities Market Size by Application (2016-2021)
9.3.2 Latin America AI-Enabled Imaging Modalities Market Size by Application (2022-2027)
9.3.3 Latin America AI-Enabled Imaging Modalities Market Size by Application (2016-2027)
9.4 Latin America AI-Enabled Imaging Modalities Market Size by Country
9.4.1 Latin America AI-Enabled Imaging Modalities Market Size by Country (2016-2021)
9.4.2 Latin America AI-Enabled Imaging Modalities Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI-Enabled Imaging Modalities Market Size (2016-2027)
10.2 Middle East & Africa AI-Enabled Imaging Modalities Market Size by Type
10.2.1 Middle East & Africa AI-Enabled Imaging Modalities Market Size by Type (2016-2021)
10.2.2 Middle East & Africa AI-Enabled Imaging Modalities Market Size by Type (2022-2027)
10.2.3 Middle East & Africa AI-Enabled Imaging Modalities Market Size by Type (2016-2027)
10.3 Middle East & Africa AI-Enabled Imaging Modalities Market Size by Application
10.3.1 Middle East & Africa AI-Enabled Imaging Modalities Market Size by Application (2016-2021)
10.3.2 Middle East & Africa AI-Enabled Imaging Modalities Market Size by Application (2022-2027)
10.3.3 Middle East & Africa AI-Enabled Imaging Modalities Market Size by Application (2016-2027)
10.4 Middle East & Africa AI-Enabled Imaging Modalities Market Size by Country
10.4.1 Middle East & Africa AI-Enabled Imaging Modalities Market Size by Country (2016-2021)
10.4.2 Middle East & Africa AI-Enabled Imaging Modalities Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Koninklijke Philips N.V.
11.1.1 Koninklijke Philips N.V. Company Details
11.1.2 Koninklijke Philips N.V. Business Overview
11.1.3 Koninklijke Philips N.V. AI-Enabled Imaging Modalities Introduction
11.1.4 Koninklijke Philips N.V. Revenue in AI-Enabled Imaging Modalities Business (2016-2021)
11.1.5 Koninklijke Philips N.V. Recent Development
11.2 Siemens Healthineers AG.
11.2.1 Siemens Healthineers AG. Company Details
11.2.2 Siemens Healthineers AG. Business Overview
11.2.3 Siemens Healthineers AG. AI-Enabled Imaging Modalities Introduction
11.2.4 Siemens Healthineers AG. Revenue in AI-Enabled Imaging Modalities Business (2016-2021)
11.2.5 Siemens Healthineers AG. Recent Development
11.3 General Electric Company
11.3.1 General Electric Company Company Details
11.3.2 General Electric Company Business Overview
11.3.3 General Electric Company AI-Enabled Imaging Modalities Introduction
11.3.4 General Electric Company Revenue in AI-Enabled Imaging Modalities Business (2016-2021)
11.3.5 General Electric Company Recent Development
11.4 Canon, Inc.
11.4.1 Canon, Inc. Company Details
11.4.2 Canon, Inc. Business Overview
11.4.3 Canon, Inc. AI-Enabled Imaging Modalities Introduction
11.4.4 Canon, Inc. Revenue in AI-Enabled Imaging Modalities Business (2016-2021)
11.4.5 Canon, Inc. Recent Development
11.5 Agfa
11.5.1 Agfa Company Details
11.5.2 Agfa Business Overview
11.5.3 Agfa AI-Enabled Imaging Modalities Introduction
11.5.4 Agfa Revenue in AI-Enabled Imaging Modalities Business (2016-2021)
11.5.5 Agfa Recent Development
11.6 Hologic
11.6.1 Hologic Company Details
11.6.2 Hologic Business Overview
11.6.3 Hologic AI-Enabled Imaging Modalities Introduction
11.6.4 Hologic Revenue in AI-Enabled Imaging Modalities Business (2016-2021)
11.6.5 Hologic Recent Development
11.7 Fujifilm
11.7.1 Fujifilm Company Details
11.7.2 Fujifilm Business Overview
11.7.3 Fujifilm AI-Enabled Imaging Modalities Introduction
11.7.4 Fujifilm Revenue in AI-Enabled Imaging Modalities Business (2016-2021)
11.7.5 Fujifilm Recent Development
11.8 Konica Minolta, Inc.
11.8.1 Konica Minolta, Inc. Company Details
11.8.2 Konica Minolta, Inc. Business Overview
11.8.3 Konica Minolta, Inc. AI-Enabled Imaging Modalities Introduction
11.8.4 Konica Minolta, Inc. Revenue in AI-Enabled Imaging Modalities Business (2016-2021)
11.8.5 Konica Minolta, Inc. Recent Development
11.9 United Health Imaging
11.9.1 United Health Imaging Company Details
11.9.2 United Health Imaging Business Overview
11.9.3 United Health Imaging AI-Enabled Imaging Modalities Introduction
11.9.4 United Health Imaging Revenue in AI-Enabled Imaging Modalities Business (2016-2021)
11.9.5 United Health Imaging Recent Development
11.10 Exo
11.10.1 Exo Company Details
11.10.2 Exo Business Overview
11.10.3 Exo AI-Enabled Imaging Modalities Introduction
11.10.4 Exo Revenue in AI-Enabled Imaging Modalities Business (2016-2021)
11.10.5 Exo Recent Development
11.11 Nanox
11.11.1 Nanox Company Details
11.11.2 Nanox Business Overview
11.11.3 Nanox AI-Enabled Imaging Modalities Introduction
11.11.4 Nanox Revenue in AI-Enabled Imaging Modalities Business (2016-2021)
11.11.5 Nanox Recent Development
11.12 Butterfly Network, Inc.
11.12.1 Butterfly Network, Inc. Company Details
11.12.2 Butterfly Network, Inc. Business Overview
11.12.3 Butterfly Network, Inc. AI-Enabled Imaging Modalities Introduction
11.12.4 Butterfly Network, Inc. Revenue in AI-Enabled Imaging Modalities Business (2016-2021)
11.12.5 Butterfly Network, Inc. Recent Development
11.13 Hyperfine
11.13.1 Hyperfine Company Details
11.13.2 Hyperfine Business Overview
11.13.3 Hyperfine AI-Enabled Imaging Modalities Introduction
11.13.4 Hyperfine Revenue in AI-Enabled Imaging Modalities Business (2016-2021)
11.13.5 Hyperfine Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
【免責事項】
https://www.globalresearch.jp/disclaimer